HQ
  • About A*STAR
    • Corporate Profile
      • A*STAR Board Members
      • Senior Management
      • Organisation Structure
      • Corporate Social Responsibility
      • Diversity at A*STAR
      • A*STAR Sustainability
    • Annual Report
    • A*STAR Global Network
  • Research
    • About A*STAR Research
    • Funding Opportunities
    • S-SEAF
    • Research Ethics
    • Biomedical Research Council
    • Science and Engineering Research Council
    • Our People
      • Highly Cited Researchers
      • Honours and Accolades
  • Innovation & Enterprise
    • About I&E
    • Innovation Offerings
  • Scholarships
  • News
    • A*STAR News
      • Publicity Highlights
      • Press Releases
      • Features
      • Committee Of Supply (COS) Debate
    • Case Studies
    • Faces of A*STAR
    • National Survey of RIE
    • Connect with Us
  • Career
  • Home
  • News
  • A*STAR News
  • COVID-19 R&D
  • A*STAR News
    • Publicity Highlights
    • Press Releases
    • Features
    • Committee Of Supply (COS) Debate
  • Case Studies
  • Faces of A*STAR
  • National Survey of RIE
  • Connect with Us
Agency for Science, Technology and Research (A*STAR)
PartnershipsCareersSuppliersContact UsWhistleblowing
  • Report Vulnerability
  • Privacy Statement
  • Terms & Conditions
  • COVID-19 R&D

    Knowing the Enemy to Fight the COVID-19 War

    01 Apr 2020
    • Whatsapp
    • Telegram
    • Facebook
    • Twitter
    • Email
    • Linked In

    Knowing the Enemy to Fight the COVID-19 War - CoVtree suncolors
    Genome tree of more than 300 Sars-Cov-2 virus sequences globally (as at 12 March 2020).

    Credit: Dr Suma Tiruvayipati, A*STAR’s Genome Institute of Singapore (GIS), Dr. Sebastian Maurer-Stroh, Deputy Executive Director of Research, A*STAR’s Bioinformatics Institute (BII), and Global Initiative on Sharing All Influenza Data (GISAID)

    Scientific and epidemiologic knowledge on COVID-19 can bring us closer to unravelling the mysteries surrounding this virus, and lead us to develop potential strategies to prevent and treat the disease it causes.

    In an interview with the Straits Times, Dr Sebastian Maurer-Stroh, Deputy Executive Director of Research at A*STAR’s Bioinformatics Institute (BII), explained that although the novel coronavirus that causes COVID-19 is genetically similar to SARS, and comes from the same family, the two viruses have key differences. This emerged from an analysis by BII scientists for GISAID, an initiative which promotes the international sharing of all influenza virus sequences. The scientists examined a key surface protein on the virus which binds to a receptor, allowing it to infect animals and sometimes people. They found that it shares 76 per cent of its genetic material with SARS in this protein, but was not closely related enough to be exactly like Sars. Dr Maurer-Stroh’s laboratory is leveraging its capabilities to analyse the virus in greater detail to identify more of its traits.

    Singapore labs join global race to learn about virus
    Prof Lisa Ng was part of the team at A*STAR that developed a kit which could test for the SARS virus in patient blood samples in 2003. (Credit: The Straits Times)

    In interviews with the Straits Times and Channel News Asia, Prof Ng, who was part of the team at A*STAR that developed a kit which could test for the SARS virus in patient samples, highlighted the importance of knowing how the virus works and how the human body reacts to it, in order to find a cure and vaccine for the virus. She explained that the immune system’s response to viruses is complex. Guided by basic understanding of biology, immunology and patient physiology, Prof Ng is analysing samples from patients in Singapore, and works closely with clinicians and healthcare workers who interact directly with patients

    Read more:

    • The Straits Times: Wuhan virus and SARS are as different as cats and dogs, researchers say
    • The Straits Times: The Big Story: How the Wuhan virus compares with SARS
    • The Straits Times: No evidence yet that different virus ‘types’ could affect severity of condition
    • The Straits Times: How the virus could have jumped from animals to humans and other questions answered
    • The Straits Times: What you need to know about the virus
    • The Straits Times Special report: On the front lines of the coronavirus
    • The Sunday Times: Singapore labs join global race to learn about virus

    Watch:

    • Channel News Asia : COVID-19 - The Invisible Enemy
    Knowing the Enemy to Fight the COVID-19 War